Fund Details
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund IDCW
| Risk | Very High |
|---|---|
| Min SIP Amount | ₹100 |
| Expense Ratio | 2.25% |
| NAV | ₹17.11 (20 Apr 2021) |
|---|---|
| Fund Started | 13 Jul 2018 |
| Fund Size | ₹2,214 Cr |
Returns
Comparison
Found nothing so far.
Found nothing so far.
Top Holdings
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Sun Pharmaceutical Inds. Ltd. | Healthcare | Equity | 10.9% |
| Cipla Ltd. | Healthcare | Equity | 9.7% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 8.6% |
| Alkem Laboratories Ltd. | Healthcare | Equity | 6.5% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 6.4% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 6.2% |
| Lupin Ltd. | Healthcare | Equity | 4.6% |
| Sanofi India Ltd. | Healthcare | Equity | 4.1% |
| Fortis Healthcare Ltd. | Healthcare | Equity | 3.2% |
| Indoco Remedies Ltd. | Healthcare | Equity | 3.2% |
Fund Managers
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund IDCW Details
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund IDCW is a Equity Mutual Fund Scheme launched by ICICI Prudential Mutual Fund. This scheme was made available to investors on 13 Jul 2018. Ihab Dalwai, Priyanka Khandelwal is the Current Fund Manager of ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund IDCW fund.The fund currently has an Asset Under Management(AUM) of ₹2,214 Cr and the Latest NAV as of 20 Apr 2021 is ₹17.11.
The ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund IDCW is rated Very High risk. Minimum SIP Investment is set to 100. Minimum Lumpsum Investment is 5000. Exit load of 1% if redeemed within 15 days.
Investment Objective
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
